Literature DB >> 15598747

Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.

Rong Rong1, Xiaoling Tang, David H Gutmann, Keqiang Ye.   

Abstract

Neurofibromatosis 2 (NF2) is a tumor suppressor, although the molecular mechanism accounting for this effect remains unknown. Here, we show that merlin exerts its activity by inhibiting phosphatidylinositol 3-kinase (PI3-kinase), through binding to PIKE-L. Wild-type merlin, but not patient-derived mutant (L64P), binds PIKE-L and inhibits PI3-kinase activity. This suppression of PI3-kinase activity results from merlin disrupting the binding of PIKE-L to PI3-kinase. In addition, merlin suppression of PI3-kinase activity as well as schwannoma cell growth is abrogated by a single PIKE-L point mutation (P187L) that cannot bind merlin but can still activate PI3-kinase. Knocking down PIKE-L with RNA interference abolishes merlin's tumor-suppressive activity. Our data support the hypothesis that PIKE-L is an important mediator of merlin growth suppression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598747      PMCID: PMC535703          DOI: 10.1073/pnas.0405971102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Molecular insights into neurofibromatosis 2.

Authors:  D H Gutmann
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

2.  Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.

Authors:  D P Huynh; S M Pulst
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

3.  Interdomain binding mediates tumor growth suppression by the NF2 gene product.

Authors:  L Sherman; H M Xu; R T Geist; S Saporito-Irwin; N Howells; H Ponta; P Herrlich; D H Gutmann
Journal:  Oncogene       Date:  1997-11-13       Impact factor: 9.867

4.  The merlin tumor suppressor localizes preferentially in membrane ruffles.

Authors:  C Gonzalez-Agosti; L Xu; D Pinney; R Beauchamp; W Hobbs; J Gusella; V Ramesh
Journal:  Oncogene       Date:  1996-09-19       Impact factor: 9.867

5.  Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells.

Authors:  S S Scherer; D H Gutmann
Journal:  J Neurosci Res       Date:  1996-12-01       Impact factor: 4.164

6.  Hepatocyte growth factor is a mitogen for Schwann cells and is present in neurofibromas.

Authors:  A Krasnoselsky; M J Massay; M C DeFrances; G Michalopoulos; R Zarnegar; N Ratner
Journal:  J Neurosci       Date:  1994-12       Impact factor: 6.167

7.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

8.  Central neurofibromatosis with bilateral acoustic neuroma.

Authors:  R Eldridge
Journal:  Adv Neurol       Date:  1981

9.  ERM (ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis.

Authors:  T Kondo; K Takeuchi; Y Doi; S Yonemura; S Nagata; S Tsukita
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

10.  Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.

Authors:  M Sainio; F Zhao; L Heiska; O Turunen; M den Bakker; E Zwarthoff; M Lutchman; G A Rouleau; J Jääskeläinen; A Vaheri; O Carpén
Journal:  J Cell Sci       Date:  1997-09       Impact factor: 5.285

View more
  51 in total

1.  A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2.

Authors:  Alejandra M Petrilli; Marisa A Fuse; Mathew S Donnan; Marga Bott; Nicklaus A Sparrow; Daniel Tondera; Julia Huffziger; Corina Frenzel; C Siobhan Malany; Christophe J Echeverri; Layton Smith; Cristina Fernández-Valle
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Matthias A Karajannis; Filippo G Giancotti
Journal:  EMBO Rep       Date:  2012-03       Impact factor: 8.807

3.  Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.

Authors:  Minja Laulajainen; Taru Muranen; Tuula A Nyman; Olli Carpén; Mikaela Grönholm
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

Review 4.  Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.

Authors:  F J Wippold; M Lubner; R J Perrin; M Lämmle; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

Review 5.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

6.  Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma.

Authors:  Hong Tang; Lingxi Jiang; Cailei Zhu; Raymond Liu; Yufeng Wu; Qian Yan; Ming Liu; Yongxu Jia; Juan Chen; Yanru Qin; Victor Ho-Fun Lee; Suxia Luo; Qiming Wang; Xin-Yuan Guan
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

Review 7.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

8.  The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.

Authors:  Katherine Striedinger; Scott R VandenBerg; Gilson S Baia; Michael W McDermott; David H Gutmann; Anita Lal
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  The phosphorylation status of merlin in sporadic vestibular Schwannomas.

Authors:  Zhaoyan Wang; Yanjun Lu; Juanjuan Tang; Haojie Wang; Hao Wu
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

10.  Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.

Authors:  Tina X Lee; Mark D Packer; Jie Huang; Elena M Akhmametyeva; Samuel K Kulp; Ching-Shih Chen; Marco Giovannini; Abraham Jacob; D Bradley Welling; Long-Sheng Chang
Journal:  Eur J Cancer       Date:  2009-04-07       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.